Abstract
Overactive bladder is a common urological diagnosis which is often untreated as patients fail to seek help for this embarrassing problem. Elizabeth Waine and Mark Stott summarise the symptoms and investigations for overactive bladder and provide an overview of the treatments available.
MeSH terms
-
Botulinum Toxins, Type A / adverse effects
-
Botulinum Toxins, Type A / pharmacology
-
Botulinum Toxins, Type A / therapeutic use
-
Humans
-
Muscarinic Antagonists / adverse effects
-
Muscarinic Antagonists / pharmacology
-
Muscarinic Antagonists / therapeutic use
-
Neuromuscular Agents / adverse effects
-
Neuromuscular Agents / pharmacology
-
Neuromuscular Agents / therapeutic use
-
Parasympatholytics / adverse effects
-
Parasympatholytics / pharmacology
-
Parasympatholytics / therapeutic use
-
Urinary Bladder, Overactive / diagnosis
-
Urinary Bladder, Overactive / drug therapy*
-
Urinary Bladder, Overactive / physiopathology
-
Urinary Bladder, Overactive / therapy
-
Urinary Incontinence, Urge / diagnosis
-
Urinary Incontinence, Urge / drug therapy*
-
Urinary Incontinence, Urge / physiopathology
-
Urinary Incontinence, Urge / therapy
Substances
-
Muscarinic Antagonists
-
Neuromuscular Agents
-
Parasympatholytics
-
Botulinum Toxins, Type A